Sigma Planning Corp bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 913 shares of the biotechnology company’s stock, valued at approximately $205,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. ICA Group Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $25,000. U.S. Capital Wealth Advisors LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $29,000. Roble Belko & Company Inc purchased a new position in Axon Enterprise during the 4th quarter valued at about $33,000. FNY Investment Advisers LLC purchased a new position in Axon Enterprise during the 1st quarter valued at about $44,000. Finally, EverSource Wealth Advisors LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $42,000. 76.47% of the stock is owned by hedge funds and other institutional investors.
Axon Enterprise Stock Performance
Shares of AXON stock opened at $203.05 on Wednesday. The company has a 50 day moving average price of $192.16 and a 200-day moving average price of $203.31. Axon Enterprise, Inc. has a 52 week low of $109.31 and a 52 week high of $229.95. The firm has a market capitalization of $15.18 billion, a PE ratio of 151.53 and a beta of 0.88. The company has a quick ratio of 2.98, a current ratio of 3.38 and a debt-to-equity ratio of 0.47.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. raised shares of Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 price target for the company in a research report on Thursday, May 11th. Needham & Company LLC reissued a “buy” rating and set a $240.00 price target on shares of Axon Enterprise in a research report on Wednesday, August 9th. Credit Suisse Group lifted their price target on shares of Axon Enterprise from $300.00 to $309.00 in a research report on Wednesday, May 10th. StockNews.com started coverage on shares of Axon Enterprise in a report on Thursday, May 18th. They issued a “hold” rating for the company. Finally, Robert W. Baird lifted their target price on shares of Axon Enterprise from $237.00 to $240.00 in a report on Thursday, May 11th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $237.91.
Read Our Latest Analysis on AXON
Insider Transactions at Axon Enterprise
In related news, Director Hadi Partovi purchased 10,000 shares of Axon Enterprise stock in a transaction dated Thursday, May 25th. The stock was purchased at an average cost of $190.75 per share, for a total transaction of $1,907,500.00. Following the completion of the purchase, the director now directly owns 388,817 shares of the company’s stock, valued at approximately $74,166,842.75. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Axon Enterprise news, Director Hadi Partovi bought 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 25th. The stock was bought at an average cost of $190.75 per share, for a total transaction of $1,907,500.00. Following the completion of the transaction, the director now owns 388,817 shares of the company’s stock, valued at approximately $74,166,842.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 22,900 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $193.12, for a total transaction of $4,422,448.00. Following the sale, the insider now owns 241,076 shares of the company’s stock, valued at $46,556,597.12. The disclosure for this sale can be found here. Insiders sold 54,458 shares of company stock worth $10,534,340 over the last three months. 6.10% of the stock is currently owned by company insiders.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising.
